| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $82K | — | -96.0% |
| Cost of Revenue | $61K | — | -96.0% |
| Gross Profit | $21K | — | -96.1% |
| R&D Expense | $2.6M | — | +2.8% |
| SG&A Expense | $1.8M | — | -16.9% |
| Operating Income | -$5.3M | — | -17.1% |
| Net Income | -$5.2M | — | -21.5% |
| EPS (Basic) | -$0.32 | — | -10.3% |
| EPS (Diluted) | -$0.32 | — | -10.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $21.8M | -15.2% | -41.0% |
| Accounts Receivable | $104K | -62.6% | -45.8% |
| Inventory | $313K | +526.0% | — |
| Current Assets | $23.3M | -15.3% | -38.9% |
| Total Assets | $24.6M | -15.0% | -38.2% |
| Current Liabilities | $3.0M | -0.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.3M | — | -90.5% |
| Capital Expenditures | $6K | — | -77.8% |
| Investing Cash Flow | -$6K | — | -102.1% |
| Financing Cash Flow | $32K | — | -99.8% |
| Free Cash Flow | -$4.3M | — | -88.5% |
| -12.7% |
| Total Liabilities | $3.5M | -2.1% | -14.7% |
| Stockholders' Equity | $21.2M | -16.8% | -40.8% |